Since we have previously shown that NT1721 decreased DNMT1 and BMI1 expression in AML cells [20] we first confirmed on the protein level that NT1721 also downregulated these genes in PDAC cells (Fig. 2a). This evidence concerns the gene BMI1 and acute myeloid leukemia.